Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes

Diabetologia
Sara J JenksJackie F Price

Abstract

We investigated whether biochemical cardiovascular risk factors and/or markers of subclinical cardiovascular disease were associated with the development of reduced renal function in people with type 2 diabetes. A cohort of 1066 Scottish men and women aged 60-74 years with type 2 diabetes from the Edinburgh Type 2 Diabetes Study were followed up for a median of 6.7 years. New-onset reduced renal function was defined as two eGFRs <60 ml-1 min-1 (1.73 m)-2 at least 3 months apart with a > 25% decline from baseline eGFR. Ankle brachial pressure index (ABI), N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity troponin T (hsTnT) were measured at baseline. Pulse wave velocity (PWV) and carotid intima media thickness were measured 1 year into follow-up. Data were analysed using Cox proportional hazards models. A total of 119 participants developed reduced renal function during follow-up. ABI, PWV, NT-proBNP and hsTnT were all associated with onset of decline in renal function following adjustment for age and sex. These associations were attenuated after adjustment for additional diabetes renal disease risk factors (systolic BP, baseline eGFR, albumin:creatinine ratio and smoking pack-years), with the exception o...Continue Reading

References

Jan 20, 1999·Kidney International·N IsmailE Ritz
Mar 2, 2005·Progress in Cardiovascular Diseases·Gary S Francis, W H Wilson Tang
May 30, 2006·Diabetes·Ravi RetnakaranUNKNOWN UKPDS Study Group
May 15, 2007·Journal of the American Society of Nephrology : JASN·Cheuk-Chun SzetoPhilip Kam-Tao Li
Jun 21, 2007·American Journal of Clinical Pathology·Majid BasitJames J Maciejko
Apr 5, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Michel ChoncholDirk Sander
May 17, 2008·Annals of Clinical Biochemistry·B CauliezA Lavoinne
Oct 14, 2008·Atherosclerosis·Michael G ShlipakMark J Sarnak
Nov 11, 2008·The American Journal of Cardiology·Sandeep R DasJames A de Lemos
Dec 17, 2008·BMC Endocrine Disorders·Jackie F PriceMark W J Strachan
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Nov 26, 2010·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·L PotierR Roussel
Jan 21, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Colin D ChueCharles J Ferro
Jun 11, 2011·International Journal of Nephrology·Antonio BellasiCarlo Ratti
Jul 9, 2011·Journal of Hypertension·Giuseppe PennoUNKNOWN Renal Insufficiency And Cardiovascular Events (RIACE) Study Group
Aug 9, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Akshay S DesaiMarc A Pfeffer
Jan 31, 2013·Journal of the American Society of Nephrology : JASN·Maryam AfkarianIan H de Boer
May 9, 2016·The Lancet. Diabetes & Endocrinology·Edward W GreggMohammed K Ali
May 20, 2016·Pulse·Anne-Sophie Garnier, Marie Briet

❮ Previous
Next ❯

Software Mentioned

Sphygmo Cor
R
SPSS

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.